Skip to content

Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship

Whole-Body Photobiomodulation Use in Professional Soccer Players During a State Championship

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07224646
Acronym
WBPBM-PSC
Enrollment
24
Registered
2025-11-05
Start date
2025-09-04
Completion date
2026-12-31
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance, Muscle Fatigue, Muscle Strength, Sports

Keywords

Phototherapy, Laser therapy, Muscle fatigue, Muscle damage, Soccer

Brief summary

This study aims to investigate the effects of whole-body photobiomodulation on professional soccer players during a state championship. The primary question is whether photobiomodulation improves recovery, reduces muscle fatigue, and enhances performance compared to standard training without photobiomodulation.

Detailed description

Detailed Description: This randomized, controlled clinical trial aims to evaluate the effects of whole-body photobiomodulation (PBM) on recovery and performance in professional soccer players during a state championship. The intervention will be performed twice weekly on non-consecutive days for 8 weeks, in combination with each athlete's standard training routine. Participants will be allocated to either an active PBM group or a sham PBM group, both following identical procedures to maintain blinding. Throughout the study, participants will complete scheduled assessments at baseline, during, and after the 8-week period to monitor performance, muscle soreness, and hematological responses. Data will be analyzed using appropriate statistical tests, with a significance level of 5% (two-tailed).

Interventions

RADIATIONWhole-Body Photobiomodulation (PBM) (Active PBM)

This intervention consists of whole-body photobiomodulation delivered using a full-body PBM device. Sessions are performed twice weekly on non-consecutive days for 8 weeks, coinciding with the athletes' standard training. The device emits therapeutic light at specified wavelengths and power, targeting the entire body. The protocol is standardized according to prior research, ensuring consistent exposure for all participants in the active arm. The intervention aims to improve muscle performance and recovery while reducing delayed onset muscle soreness (DOMS).

RADIATIONSham PBM

Intervention Description (Sham PBM): Participants receive a sham photobiomodulation intervention using the same device and schedule, but without emission of therapeutic light. The procedure mimics the active intervention to maintain blinding while allowing comparison of outcomes, including muscle performance, DOMS, and blood markers.

Sponsors

Universidade Federal de Sao Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Triple-masked trial. Participants wear protective eyewear; the sham device is physically identical and runs the same schedule, fan noise, and indicator covers, but emits no therapeutic light. Operators who run sessions are distinct from outcomes assessors; participants and assessors are unaware of group assignment. Scheduling and room procedures minimize cross-talk between teams. Randomization and assignment are concealed using sealed, opaque envelopes prepared by an independent researcher.

Intervention model description

Model Description: Participants are randomly assigned to two parallel groups: an Active Photobiomodulation (PBM) group and a Sham PBM group. Both groups undergo the same training schedule and assessment timeline, but only the active group receives therapeutic light exposure. There is no crossover between groups throughout the 8-week intervention period.

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male professional soccer players currently competing in the championship * Age 18-35 years * Training frequency ≥5 times per week * Able to attend all PBM/sham sessions and all assessments during the 8-week intervention * Signed informed consent

Exclusion criteria

* Lower-limb musculoskeletal injury in the last 6 months or currently receiving treatment * Current use of phototherapy or any other recovery-enhancing modality * Chronic medical conditions that may affect performance or recovery * Known sensitivity or contraindication to light-based therapies * Inability to comply with the intervention or training schedule

Design outcomes

Primary

MeasureTime frameDescription
Delayed Onset Muscle Soreness (DOMS)Baseline (T1), weekly (T2, weeks 1-8), and end of week 8 (T3).Pain intensity measured using the Numeric Rating Scale (NRS; 0-10 points; higher scores = worse pain) during a maximal voluntary knee-extension contraction in sitting. Pain location/extent captured with a standardized pain drawing (exploratory). Primary analysis uses NRS.

Secondary

MeasureTime frameDescription
Knee Extensor Strength (Hand-Held Dynamometry)Baseline (T1), weekly (T2, weeks 1-8), end of week 8 (T3)Peak force of dominant-leg knee extensors measured with a handheld dynamometer in standardized seated position; mean of two MVC attempts used for analysis.
Squat Jump (SJ) HeightBaseline (T1), weekly (T2, weeks 1-8), end of week 8 (T3) Unit: cmVertical jump height (cm) from Squat Jump (SJ) with hands on hips; mean of two trials; flight-time method on contact device.
Countermovement Jump (CMJ) HeightBaseline (T1), weekly (T2, weeks 1-8), end of week 8 (T3)Vertical jump height (cm) from Countermovement Jump (CMJ) with hands on hips; mean of two trials; flight-time method on contact device.

Countries

Brazil

Contacts

Primary ContactItalo A Oliveira, MSc
italoao@estudante.ufscar.br+55 19 997190361

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026